Studies related to Nasal Congestion and Astragalus membranaceus

Efficacy And Safety Of Astragalus Membranaceus In The Treatment Of Patients With Seasonal Allergic Rhinitis

Effect Decrease
Trial Design Double blind
Trial Length 1-6 months
Number of Subjects 41
Sex Both Genders
Age Range 18-29, 30-44
Notes for this study:
After 6 weeks of oral dosing of an 18:1 Astragalus Membanaceus extract at 80mg (standardized to 40% polysaccharides) with calcium-aluminum silicate as a mineral carrier.

After 3 weeks of supplementation, there was a significant reduction in symptoms of allergic rhinitus such as rhinorrhea, sneezing, and itching.